default image

Urologie

Information and services of the department

  • Number of inpatient cases: 20

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 5
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0) 4
Malignant neoplasm of prostate (C61) not specified
Malignant neoplasm of testis (C62.9) not specified
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) not specified
Malignant neoplasm of bladder - Malignant neoplasm of ureteric orifice (C67.6) not specified
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) not specified
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) not specified
Urethral stricture (N35.9) not specified
Hydrocele and spermatocele - Other hydrocele (N43.2) not specified
Treatment Number
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 14
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 6
Injection or administration of medicines into the urinary bladder (8-132.3) 4
Surgical dilatation of the urethral opening (5-581.1) 0
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.0) 0
Surgical occlusion of a hydrocele on the testicle (5-611) 0
Surgical removal of a testicle (5-622.5) 0
Surgical removal of the tissue around the epididymis (5-631.1) 0
Surgical removal of the tissue around the epididymis (5-631.x) 0
Injection or administration of medicines into the urinary bladder (8-132.0) 0

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
53 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
43 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
43 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)
No. Training in other healing professions Comment
HB13 Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB15 Anaesthesia technical assistant (m/f)
HB03 Physical therapist / physiotherapist (m/f) Es werden Praktikumsplätze für Auszubildende angeboten.
HB19 Nursing professionals
HB10 Midwife (m/f)
HB07 Surgical technical assistant (m/f)

Silvia Roßbach

Ehrenamtliche Patientenfürsprecherin

Phone: 0391 -7262-880
Mail: ed.tfitsneiram-ts@rehcerpsreufnetneitap

Anja Oberhack

Qualitäts- und Risikomanagement / Beschwerdemanagement / Datenschutz

Phone: 0391 -7262-042
Mail: ed.tfitsneiram-ts@kcahrebo.ajna

Anja Oberhack

Qualitäts- und Risikomanagement / Beschwerdemanagement

Phone: 0391 -7262-042
Mail: ed.tfitsneiram-ts@kcahrebo.ajna

Dr. med. Michael Ludwig

Ärztlicher Direktor

Phone: 0391 -7262-074
Mail: ed.tfitsneiram-ts@giwdul

Dr. med. Michael Ludwig

Ärztlicher Direktor

Phone: 0391 -7262-074
Mail: ed.tfitsneiram-ts@giwdul